Cargando…

Detecting human melanoma cell re-differentiation following BRAF or heat shock protein 90 inhibition using photoacoustic and magnetic resonance imaging

Targeted therapies specific to the BRAF-MEK-ERK signaling pathway have shown great promise in the treatment of malignant melanoma in the last few years, with these drugs now commonly used in clinic. Melanoma cells treated using these agents are known to exhibit increased levels of melanin pigment an...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shah, Anant, Delgado-Goni, Teresa, Casals Galobart, Teresa, Wantuch, Slawomir, Jamin, Yann, Leach, Martin O., Robinson, Simon P., Bamber, Jeffrey, Beloueche-Babari, Mounia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2017
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5557970/ https://www.ncbi.nlm.nih.gov/pubmed/28811486 http://dx.doi.org/10.1038/s41598-017-07864-8

Ejemplares similares

Increased inflammatory lipid metabolism and anaplerotic mitochondrial activation follow acquired resistance to vemurafenib in BRAF-mutant melanoma cells
por: Delgado-Goñi, Teresa, et al.
Publicado: (2019)

Monocarboxylate transporter 1 blockade with AZD3965 inhibits lipid biosynthesis and increases tumour immune cell infiltration
por: Beloueche-Babari, Mounia, et al.
Publicado: (2020)

Modulation of melanoma cell phospholipid metabolism in response to heat shock protein 90 inhibition
por: Beloueche-Babari, Mounia, et al.
Publicado: (2010)

Metabolic assessment of the action of targeted cancer therapeutics using magnetic resonance spectroscopy
por: Beloueche-Babari, M, et al.
Publicado: (2010)

Model Free Approach to Kinetic Analysis of Real-Time Hyperpolarized (13)C Magnetic Resonance Spectroscopy Data
por: Hill, Deborah K., et al.
Publicado: (2013)

Acute tumour response to the MEK1/2 inhibitor selumetinib (AZD6244, ARRY-142886) evaluated by non-invasive diffusion-weighted MRI
por: Beloueche-Babari, M, et al.
Publicado: (2013)

Quantitative photoacoustic imaging study of tumours in vivo: Baseline variations in quantitative measurements
por: Martinho Costa, Márcia, et al.
Publicado: (2018)

Acquired resistance to EGFR tyrosine kinase inhibitors alters the metabolism of human head and neck squamous carcinoma cells and xenograft tumours
por: Beloueche-Babari, M, et al.
Publicado: (2015)

Acquired resistance to PI3K/mTOR inhibition is associated with mitochondrial DNA mutation and glycolysis
por: Koh, King Xin, et al.
Publicado: (2017)

Optically and acoustically triggerable sub-micron phase-change contrast agents for enhanced photoacoustic and ultrasound imaging
por: Lin, Shengtao, et al.
Publicado: (2017)

Magnetic resonance detects changes in phosphocholine associated with Ras activation and inhibition in NIH 3T3 cells
por: Ronen, S M, et al.
Publicado: (2001)

Heat Shock Protein 90 (Hsp90) Expression and Breast Cancer
por: Zagouri, Flora, et al.
Publicado: (2012)

Antibodies to Heat Shock Proteins 90α and 90β in Psoriasis
por: Damasiewicz-Bodzek, Aleksandra, et al.
Publicado: (2020)

Photoacoustics and photoacoustic spectroscopy
por: Rosencwaig, Allan
Publicado: (1980)

Immunotherapeutic targeting of HSP90 client proteins in BRAF-inhibitor resistant melanoma
por: Fecek, Ronald J, et al.
Publicado: (2015)

Potential role of heat shock protein 90 (Hsp90) in HIV uncoating
por: Joshi, Pheroze, et al.
Publicado: (2011)

Heat Shock Protein 90 (HSP90) and Her2 in Adenocarcinomas of the Esophagus
por: Slotta-Huspenina, Julia, et al.
Publicado: (2014)

Circulating heat shock protein 90 (Hsp90) and autoantibodies to Hsp90 are increased in patients with atopic dermatitis
por: Sitko, Krzysztof, et al.
Publicado: (2021)

Heat shock protein 90 in neurodegenerative diseases
por: Luo, Wenjie, et al.
Publicado: (2010)

Heat Shock Protein 90 in Alzheimer's Disease
por: Ou, Jiang-Rong, et al.
Publicado: (2014)

Heat shock protein 90 inhibition in the endothelium
por: Barabutis, Nektarios
Publicado: (2023)

Re: comparison between two shock wave regimens using frequencies of 60 and 90 impulses per minute for urinary stones
por: Ho, Christopher C K
Publicado: (2011)

Targeting CDK2 overcomes melanoma resistance against BRAF and Hsp90 inhibitors
por: Azimi, Alireza, et al.
Publicado: (2018)

The efficacy of re-challenge with BRAF inhibitors after previous progression to BRAF inhibitors in melanoma: A retrospective multicenter study
por: Tietze, Julia K., et al.
Publicado: (2018)

Recognition of BRAF by CDC37 and Re-Evaluation of the Activation Mechanism for the Class 2 BRAF-L597R Mutant
por: Bjorklund, Dennis M., et al.
Publicado: (2022)

Identification and Characterization of Three Heat Shock Protein 90 (Hsp90) Homologs in the Brown Planthopper
por: Chen, Xuan, et al.
Publicado: (2020)

Identification of Isoform-Selective Ligands for the Middle Domain of Heat Shock Protein 90 (Hsp90)
por: Mak, Oi Wei, et al.
Publicado: (2019)

Extracellular Heat Shock Protein-90 (eHsp90): Everything You Need to Know
por: Jay, Daniel, et al.
Publicado: (2022)

Silencing of heat shock protein 90 (hsp90): Effect on development and infectivity of Ichthyophthirius multifiliis
por: Saleh, Mona, et al.
Publicado: (2023)

Traditional and Novel Mechanisms of Heat Shock Protein 90 (HSP90) Inhibition in Cancer Chemotherapy Including HSP90 Cleavage
por: Park, Sangkyu, et al.
Publicado: (2019)

Heat shock protein90 in lobular neoplasia of the breast
por: Zagouri, Flora, et al.
Publicado: (2008)

The Hexameric Structures of Human Heat Shock Protein 90
por: Lee, Cheng-Chung, et al.
Publicado: (2011)

Heat Shock Protein 90 regulates encystation in Entamoeba
por: Singh, Meetali, et al.
Publicado: (2015)

Effects of Heat Shock Protein 90 Inhibition In the Lungs
por: Uddin, Mohammad A., et al.
Publicado: (2020)

Preclinical Three-Dimensional Vibrational Shear Wave Elastography for Mapping of Tumour Biomechanical Properties In Vivo
por: Parasaram, Vaideesh, et al.
Publicado: (2022)

The interaction between RE1-silencing transcription factor (REST) and heat shock protein 90 as new therapeutic target against Huntington’s disease
por: Orozco-Díaz, Raúl, et al.
Publicado: (2019)

Molecular docking and pharmacophore studies of heterocyclic compounds as Heat shock protein 90 (Hsp90) Inhibitors
por: Baby, Suby T, et al.
Publicado: (2016)

Nonlinear mechanisms in photoacoustics—Powerful tools in photoacoustic imaging
por: Gao, Rongkang, et al.
Publicado: (2021)

Targeting Heat Shock Protein 90 for the Treatment of Malignant Pheochromocytoma
por: Giubellino, Alessio, et al.
Publicado: (2013)

Activity of the Heat Shock Protein 90 Inhibitor Ganetespib in Melanoma
por: Wu, Xinqi, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_adnlt61jsg200qphb6blmpolka